Delivery Order SPE2DB22D1041-SPE2DB23FP5QR
Award Date 5/2/23
Potential Completion Date 5/3/23
Potential Value $4.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,395.27 firm fixed-price delivery order is for the supply of Fenofibrate 145 mg tablets, a medication used to treat high cholesterol and triglyceride levels. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
- This federal contract award, valued at $34,615.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Fenofibrate 145 mg tablets, a medication used to treat high cholesterol and triglyceride levels. The contract has an ultimate completion date of February 28, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant...
- This federal contract award, with ID SPE2DX15D3404|SPE2DX24F0XUP, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,320.80 Firm Fixed Price Delivery Order is for the supply of Fenofibrate 145 mg Tablet UD 100s, a cardiovascular medication. The contract is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Fenofibrate 145 mg tablets. The contract, valued at $4,712.97, is a firm fixed-price delivery order contract that runs through August 18, 2023. The contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,658.44 firm-fixed-price delivery order is for the supply of Fenofibrate 145 mg tablets. The contract has an ultimate completion date of May 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime...
- This federal contract award is for the delivery of Fenofibrate 145 mg tablets to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $10,372.39 and was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 17, 2023. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
- This federal contract award, valued at $1,021.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fenofibrate 145 mg Tablet UD 30s, a generic pharmaceutical product. The award is not designated as a set-aside contract. It represents a single delivery order against a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,197.99 firm fixed-price delivery order covers the supply of 4,562,888,387 units of Fenofibrate 145 mg tablets. The award has an ultimate completion date of November 24, 2023 and was not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $68,193.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Fenofibrate 145 mg tablets, a medication used to treat high cholesterol and triglyceride levels. The contract has an ultimate completion date of January 30, 2025 and utilizes a Firm Fixed Price pricing structure. Amerisourcebergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,407.74, is a Firm Fixed Price Delivery Order for the supply of Fenofibrate 48 mg Tablet Unit Dose (30s). The contract has an ultimate completion date of June 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...